(Rac) -HA14-1
(Rac) -HA14-1 is the racemic form of HA14-1. HA14-1 is a Bcl-2/Bcl-xL antagonist with an IC50 of approximately 9 μM against Bcl-2[1].
Product Specifications
CAS Number
927635-64-1
UNSPSC
12352005
Target
Bcl-2 Family
Type
Reference compound
Related Pathways
Apoptosis
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rac-ha14-1.html
Smiles
N#CC(C1C2=CC(Br)=CC=C2OC(N)=C1C(OCC)=O)C(OCC)=O
Molecular Formula
C17H17BrN2O5
Molecular Weight
409.23
References & Citations
[1]Azmi AS, et al. Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy. J Cell Physiol. 2009 Jan;218 (1) :13-21.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400525-500 1x 500 µL
CD63 (MX-49.129.5), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682216-100 1x 100 µL
CD50 / ICAM3 (CG106), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880745-100 1x 100 µL
CD45 / LCA (2B11 + PD7/26), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 